The normalisation would work towards allowing the drug companies to be comfortable with a rent-seeking scenario, where they have a huge population that has little choice but to use their services, at whatever cost.

And of course, that might mean an actual cure is detrimental to the bottom line, which might impact funding for any of these studies.